Fujinaga M, Sielecki A R, Read R J, Ardelt W, Laskowski M, James M N
Department of Biochemistry, University of Alberta, Edmonton, Canada.
J Mol Biol. 1987 May 20;195(2):397-418. doi: 10.1016/0022-2836(87)90659-0.
The molecular structure of the complex between bovine pancreatic alpha-chymotrypsin (EC 3.4.4.5) and the third domain of the Kazal-type ovomucoid from Turkey (OMTKY3) has been determined crystallographically by the molecular replacement method. Restrained-parameter least-squares refinement of the molecular model of the complex has led to a conventional agreement factor R of 0.168 for the 19,466 reflections in the 1.8 A (1 A = 0.1 nm) resolution shell [I greater than or equal to sigma (I)]. The reactive site loop of OMTKY3, from Lys13I to Arg21I (I indicates inhibitor), is highly complementary to the surface of alpha-chymotrypsin in the complex. A total of 13 residues on the inhibitor make 113 contacts of less than 4.0 A with 21 residues of the enzyme. A short contact (2.95 A) from O gamma of Ser195 to the carbonyl-carbon atom of the scissile bond between Leu18I and Glu19I is present; in spite of it, this peptide remains planar and undistorted. Analysis of the interactions of the inhibitor with chymotrypsin explains the enhanced specificity that chymotrypsin has for P'3 arginine residues. There is a water-mediated ion pair between the guanidinium group on this residue and the carboxylate of Asp64. Comparison of the structure of the alpha-chymotrypsin portion of this complex with the several structures of alpha and gamma-chymotrypsin in the uncomplexed form shows a high degree of structural equivalence (root-mean-square deviation of the 234 common alpha-carbon atoms averages 0.38 A). Significant differences occur mainly in two regions Lys36 to Phe39 and Ser75 to Lys79. Among the 21 residues that are in contact with the ovomucoid domain, only Phe39 and Tyr146 change their conformations significantly as a result of forming the complex. Comparison of the structure of the OMTKY3 domain in this complex to that of the same inhibitor bound to a serine proteinase from Streptomyces griseus (SGPB) shows a central core of 44 amino acids (the central alpha-helix and flanking small 3-stranded beta-sheet) that have alpha-carbon atoms fitting to within 1.0 A (root-mean-square deviation of 0.45 A) whereas the residues of the reactive-site loop differ in position by up to 1.9 A (C alpha of Leu18I). The ovomucoid domain has a built-in conformational flexibility that allows it to adapt to the active sites of different enzymes. A comparison of the SGPB and alpha-chymotrypsin molecules is made and the water molecules bound at the inhibitor-enzyme interface in both complexes are analysed for similarities and differences.
通过分子置换法,已通过晶体学确定了牛胰α-糜蛋白酶(EC 3.4.4.5)与来自土耳其的Kazal型卵类粘蛋白第三结构域(OMTKY3)之间复合物的分子结构。对该复合物分子模型进行的约束参数最小二乘精修,使得在1.8 Å(1 Å = 0.1 nm)分辨率壳层中的19466个反射的常规拟合因子R为0.168 [I大于或等于σ(I)]。OMTKY3的反应位点环,从Lys13I到Arg21I(I表示抑制剂),在复合物中与α-糜蛋白酶的表面高度互补。抑制剂上共有13个残基与酶的21个残基形成了113个距离小于4.0 Å的接触。存在从Ser195的Oγ到Leu18I和Glu19I之间可裂解键的羰基碳原子的短接触(2.95 Å);尽管如此,该肽仍保持平面且未变形。对抑制剂与糜蛋白酶相互作用的分析解释了糜蛋白酶对P'3精氨酸残基具有增强的特异性。该残基上的胍基与Asp64的羧酸盐之间存在水介导的离子对。将该复合物的α-糜蛋白酶部分的结构与未复合形式的α和γ-糜蛋白酶的几种结构进行比较,显示出高度的结构等效性(234个共同α-碳原子的均方根偏差平均为0.38 Å)。显著差异主要出现在两个区域,即Lys36至Phe39和Ser75至Lys79。在与卵类粘蛋白结构域接触的21个残基中,只有Phe39和Tyr146由于形成复合物而其构象发生了显著变化。将该复合物中OMTKY3结构域的结构与结合到灰色链霉菌丝氨酸蛋白酶(SGPB)上的相同抑制剂的结构进行比较,发现有一个44个氨基酸的中央核心(中央α-螺旋和侧翼小的3股β-折叠),其α-碳原子的拟合误差在1.0 Å以内(均方根偏差为0.45 Å),而反应位点环的残基位置差异高达1.9 Å(Leu18I的Cα)。卵类粘蛋白结构域具有内在的构象灵活性,使其能够适应不同酶的活性位点。对SGPB和α-糜蛋白酶分子进行了比较,并分析了两种复合物中结合在抑制剂-酶界面的水分子的异同。